ArticleNPJ Parkinson's disease2025

Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.

Gennaro Pagano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.